Assays of Fatty Acid β-Oxidation Activity

Methods in Cell Biology

Volumn 80, Issue , 2007, Pages 179-197

  Bennett, Michael J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID; ACYLCARNITINE; CARNITINE; DRUG DERIVATIVE; FATTY ACID; GLYCINE;

ACTIVE TRANSPORT; BIOLOGICAL MODEL; ENZYMOLOGY; HUMAN; LIPID METABOLISM; METABOLISM; MITOCHONDRION; OXIDATION REDUCTION REACTION; REVIEW; URINE;

ACIDS; BIOLOGICAL TRANSPORT, ACTIVE; CARNITINE; FATTY ACIDS; GLYCINE; HUMANS; LIPID METABOLISM; MITOCHONDRIA; MODELS, BIOLOGICAL; OXIDATION-REDUCTION;

EID: 34147193455     PISSN: 0091679X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0091-679X(06)80009-9     Document Type: Review

References (28)

1. Bennett M.J., and Narayan S.B. Carnitine palmitoyltransferase 1A. "Gene Reviews." (2005). Available at www.genetests.org
2. Bennett M.J., Russell L.K., Tokunada C., Narayan S.B., Tan L., Seegmiller A., Boriack R.L., and Strauss A.W. Reye-like syndrome resulting from novel missense mutations in mitochondrial medium- and short-chain L-3-hydroxyacyl-CoA dehydrogenase. Mol. Genet. Metab. 88 (2006) 74-79
3. Campbell S.E., Tandon N.T., Woldegiorgis G., Luiken J.J.F.P., Glatz J.F.C., and Bonen A. A novel function for fatty acid translocase (FAT)/CD36. J. Biol. Chem. 279 (2004) 36235-36241
4. Chace D.H., Kalas T.A., and Naylor E.W. Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin. Chem. 49 (2003) 1797-1817
5. Ensenauer R., He M., Willard J.M., Goetzman E.S., Corydon T.J., Vandahl B.B., Mohsen A.W., and Vockley J. Human acyl-CoA dehydrogenase-9 plays a novel role in the mitochondrial beta-oxidation of unsaturated fatty acids. J. Biol. Chem. 280 (2005) 32309-32316
6. Frazier D.M., Millington D.S., McCandless S.E., Koeberl D.D., Weavil S.D., Chaing S.H., and Muenzer J. The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005. J. Inherit. Metab. Dis. 29 (2006) 76-85
7. Hale D.E., Stanley C.A., and Coates P.M. Genetic defects of acyl-CoA dehydrogenases: Studies using an electron transfer flavoprotein reduction assay. Prog. Clin. Biol. Res. 321 (1990) 333-348
8. Kumps A., Duez P., and Mardens Y. Metabolic, nutritional, iatrogenic, and artifactual sources of urinary organic acids: A comprehensive table. Clin. Chem. 48 (2002) 708-717
9. McGarry J.D., and Brown N.F. The mitochondrial carnitine palmitoyl-transferase system. From concept to molecular analysis. Eur. J. Biochem. 244 (1997) 1-14
10. Murthy M.S., Kamanna V.S., and Pande S.V. A carnitine/acylcarnitine translocase assay applicable to biopsied specimens without requiring mitochondrial isolation. Biochem. J. 236 (1986) 143-148
11. Nada M.A., Chace D.H., Sprecher H., and Roe C.R. Investigation of β-oxidation in normal and MCAD-deficient human fibroblasts using tandem mass spectrometry. Biochem. Mol. Med. 54 (1995) 59-66
12. Narayan S.B., Boriack R.L., Messmer B., and Bennett M.J. Establishing a normal range for measurement of flux through the mitochondrial fatty acid oxidation pathway. Clin. Chem. 51 (2005) 644-646
13. Oey N.A., Den Boer M.E.J., Wijberg F.A., Vekemans M., Auge J., Steiner C., Wanders R.J.A., Waterham H.R., Ruiter J.P.N., and Attie-Bitach T. Long-chain fatty acid oxidation during early human development. Pediatr. Res. 56 (2005) 755-759
14. -3H] Oleic acid. J. Inherit. Metab. Dis. 20 (1997) 415-419
15. Rinaldo P., Matern D., and Bennett M.J. Fatty acid oxidation disorders. Annu. Rev. Physiol. 64 (2002) 477-502
16. Rinaldo P., O'Shea J.J., Coates P.M., Hale D.E., Stanley C.A., and Tanaka K. Medium-chain acyl-CoA dehydrogenase deficiency: Diagnosis by stable isotope dilution measurement of urinary n-hexanoylglycine and 3-phenyl propionylglycine. N. Engl. J. Med. 319 (1988) 1308-1313
17. Roe C.R., and Ding J. Mitochondrial fatty acid oxidation disorders. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). "The Metabolic & Molecular Bases of Inherited Disease". 8th edn (2001), McGraw-Hill, New York 2297-2326
18. Saudubray J.-M., Coude F.-X., Demaugre F., Johnson C., Gibson K.M., and Nyhan W.L. Oxidation of fatty acids in cultured fibroblasts: A model system for the detection and study of defects in oxidation. Pediatr. Res. 16 (1982) 877-881
19. Seargeant L.E., Balachandra K., Malory C., Dilling L.A., and Greenberg C.R. A simple screening test for fatty acid oxidation defects using whole blood palmitate oxidation. J. Inherit. Metab. Dis. 22 (1999) 740-746
20. Shekhawat P., Bennett M.J., Sadovsky Y., Nelson D.M., Rakheja D., and Strauss A.W. Human placenta metabolizes fatty acids: Implications for fetal fatty acid oxidation disorders and maternal liver disease. Am. J. Physiol. Endocrinol. Metab. 284 (2003) E1098-E1105
21. Shen J.J., Matern D., Millington D.S., Hillman S., Feezor M.D., Bennett M.J., Qumsiyeh M., Kahler S.G., Chen Y.-T., and Van Hove J.L.K. Acylcarnitines in fibroblasts of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and other fatty acid oxidation defects. J. Inherit. Metab. Dis. 23 (2000) 27-44
22. Stanley C.A., Bennett M.J., and Mayatepek E. Disorders of mitochondrial fatty acid oxidation and related metabolic pathways. In: Fernandes J., Saudubray J.-M., Van den Berghe G., and Walter J.H. (Eds). "Inborn Metabolic Diseases: Diagnosis and Treatment" (2006), Springer, Heidelberg 175-190
23. Stanley C.A., Berry G., Hale D.E., Bennett M.J., Willi S., and Treem W. Renal handling of carnitine in secondary carnitine deficiency disorders. Pediatr. Res. 34 (1993) 89-97
24. Stanley C.A., Hale D.E., Berry G.T., Deleeuw S., Boxer J., and Bonnefont J.-P. A deficiency of carnitine-acylcarnitine translocase in the inner mitochondrial membrane. N. Engl. J. Med. 327 (1992) 19-23
25. Treem W.R., Stanley C.A., Finegold D.N., Hale D.E., and Coates P.M. Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle, and fibroblasts. N. Engl. J. Med. 319 (1988) 1331-1336
26. Wanders R.J.A., IJlst L., Poggi F., Bonnefont J.-P., Munnich A., Rabier D., and Saudubray J.-M. Human trifunctional protein deficiency: A new disorder of mitochondrial fatty aid beta-oxidation. Biochem. Biophys. Res. Commun. 188 (1992) 1139-1145
27. Wanders R.J.A., IJlst L., van Elk E., de Klerk J.B.C., and Przyrembel H. Octanoate and palmitate β-oxidation in human leukocytes: Implications for rapid diagnosis of fatty acid β-oxidation. J. Inherit. Metab. Dis. 14 (1991) 317-320
28. Yang S.-Y., He X.-J., and Schulz H. 3-Hydroxyacyl-CoA dehydrogenase and short-chain 3-hydroxyacyl-CoA dehydrogenase in human health and disease. FEBS J. 272 (2005) 4874-4883